Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum

Béatrice Botia1, Valérie Jolivel, Delphine Burel

  • 1INSERM U982, DC2N, University of Rouen, Mont-Saint-Aignan, France.

Neurotoxicity Research
|April 28, 2010
PubMed

Insights

Pituitary adenylate cyclase-activating polypeptide (PACAP) protects developing rat cerebellum from alcohol toxicity. PACAP counteracts ethanol

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • The developing cerebellum is vulnerable to alcohol during early neurogenesis.
  • Pituitary adenylate cyclase-activating polypeptide (PACAP) shows neuroprotective effects in vitro.

Purpose of the Study:

  • To investigate PACAP's ability to counteract ethanol toxicity in vivo in young rats.
  • To explore PACAP's effects on alcohol-induced gene expression and cell survival.

Main Methods:

  • 8-day-old rats were administered ethanol and/or PACAP.
  • Behavioral tests (negative geotaxis) were performed.
  • Gene expression (c-jun, caspase-3, α6 GABA A, neuroD2) and cell counts were analyzed.

Main Results:

  • PACAP improved locomotor activity in ethanol-exposed rats.
  • Ethanol-induced pro-apoptotic gene expression was partially blocked by PACAP.
  • PACAP counteracted ethanol's inhibition of neuronal differentiation markers and prevented granule cell loss.

Conclusions:

  • PACAP effectively counteracts the in vivo neurotoxic effects of ethanol on the developing cerebellum.
  • PACAP's beneficial effects on locomotor activity precede its impact on cell survival, suggesting it blocks detrimental actions on neuronal differentiation.

Related Concept Videos